000			01395 a2200385 4500
005			20250517003041.0
264		0	_c20161213
008			201612s 0 0 eng d
022			_a1646-0758
024	7		_a10.20344/amp.5257 _2doi
040			_aNLM _beng _cNLM
100	1		_aSantos, Isabel Fonseca
245	0	0	_aEconomic analysis of rivaroxaban for the treatment and long-term prevention of venous thromboembolism in Portugal. _h[electronic resource]
260			_bActa medica portuguesa _c
300			_a615-24 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnticoagulants _xtherapeutic use
650	0	4	_aCosts and Cost Analysis
650	0	4	_aEnoxaparin _xtherapeutic use
650	0	4	_aFactor Xa Inhibitors _xeconomics
650	0	4	_aHumans
650	0	4	_aModels, Economic
650	0	4	_aPortugal
650	0	4	_aQuality-Adjusted Life Years
650	0	4	_aRivaroxaban _xeconomics
650	0	4	_aTime Factors
650	0	4	_aVenous Thromboembolism _xdrug therapy
650	0	4	_aWarfarin _xtherapeutic use
700	1		_aPereira, Sónia
700	1		_aMcLeod, Euan
700	1		_aGuillermin, Anne-Laure
700	1		_aChatzitheofilou, Ismini
773	0		_tActa medica portuguesa _gvol. 27 _gno. 5 _gp. 615-24
856	4	0	_uhttps://doi.org/10.20344/amp.5257 _zAvailable from publisher's website
999			_c24365460 _d24365460